They demonstrated that overexpression of IL13Rα2 in patients with melanoma led to increased expression of amphiregulin, a component of the EGF family and a proangiogenic factor, resulting in the stimulation of angiogenesis and tumor growth. This evidence concerns the gene IL13RA2 and melanoma.